Lung cancer drug therapy in Hungary – 3-year experience

Por Moldvay, Judit, Rokszin, György, Abonyi-Tóth, Zsolt, Katona, Lajos, Fábián, Katalin, Kovács, Gábor
Publicado no Onco Targets Ther (2015)

KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis

Por Lohinai, Zoltan, Klikovits, Thomas, Moldvay, Judit, Ostoros, Gyula, Raso, Erzsebet, Timar, Jozsef, Fabian, Katalin, Kovalszky, Ilona, Kenessey, István, Aigner, Clemens, Renyi-Vamos, Ferenc, Klepetko, Walter, Dome, Balazs, Hegedus, Balazs
Publicado no Sci Rep (2017)

Evaluating the significance of density, localization, and PD-1/PD-L1 immunopositivity of mononuclear cells in the clinical course of lung adenocarcinoma patients with brain metasta...

Por Téglási, Vanda, Reiniger, Lilla, Fábián, Katalin, Pipek, Orsolya, Csala, Irén, Bagó, Attila G., Várallyai, Péter, Vízkeleti, Laura, Rojkó, Lívia, Tímár, József, Döme, Balázs, Szállási, Zoltán, Swanton, Charles, Moldvay, Judit
Publicado no Neuro Oncol (2017)

Rational Design of DNA-Expressed Stabilized Native-Like HIV-1 Envelope Trimers

Por Aldon, Yoann, McKay, Paul F., Allen, Joel, Ozorowski, Gabriel, Felfödiné Lévai, Réka, Tolazzi, Monica, Rogers, Paul, He, Linling, de Val, Natalia, Fábián, Katalin, Scarlatti, Gabriella, Zhu, Jiang, Ward, Andrew B., Crispin, Max, Shattock, Robin J.
Publicado no Cell Rep (2018)